Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check4 days agoChange DetectedA new revision entry, Revision: v3.3.4, was added to the Study Record Versions list, and the previous Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check12 days agoChange DetectedA new Study Status entry on 2026-01-02 was added to the record history, and the 2024-12-02 entry was removed.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.3 was added to the Study Record Versions list, indicating a new update to the record. The footer now omits the HHS Vulnerability Disclosure link and Revision: v3.3.2.SummaryDifference0.2%

- Check48 days agoChange DetectedThe Record History section shows minor updates: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe Record History shows a new Revision: v3.3.1 added and Revision: v3.2.0 removed, reflecting a minor update to the study record versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedA site-wide funding outage notice has been removed from the page, and the rest of the study record remains visible.SummaryDifference0.7%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.